In the early stages of AD pathology, TREM2 activates the PI3K/Akt pathway downstream of the DAP12 signaling pathway, enhancing microglial survival and increasing their numbers to cope with neuroinflammation and pathological deposits (Figure 1; Sayed et al., 2021). This evidence concerns the gene TREM2 and Alzheimer disease.